For investors seeking momentum, SPDR NYSE Technology ETF XNTK is probably on radar. The fund just hit a 52-week high, and is up about 51% from its 52-week low price of $110.34/share.But are more gains in store for this ETF? Let’s take a quick look at the fund and the near
Have you been paying attention to shares of Seiko Epson (SEKEY)? Shares have been on the move with the stock up 8.1% over the past month. The stock hit a new 52-week high of $10.03 in the previous session. Seiko Epson has gained 34.9% since the start of the year compared
Have you been paying attention to shares of ScanSource (SCSC)? Shares have been on the move with the stock up 32.5% over the past month. The stock hit a new 52-week high of $38.47 in the previous session. ScanSource has gained 43.9% since the start of the year compared to
SPECIAL ALERT: The latest episode of the Zacks Ultimate Strategy Session will be available for viewing no later than this Thursday, September 9. Kevin Matras, Kevin Cook, Daniel Laboe, Dr. John Blank and Sheraz Mian will cover the investment landscape from several angle
Technology stocks were mixed premarket Wednesday. The Technology Select Sector SPDR ETF (XLK) was up 0.01% and the Semiconductor Sector Index Fund (SOXX) was 0.56% lower recently.
The Nasdaq Composite Index has been hitting a series of record highs since the start of the pandemic. In fact, the tech-heavy index topped 15,000 for the first-time last month. The year 2020 can be fully attributed to the Nasdaq. Though the tech-heavy Nasdaq was out of fa
If you've been stuck searching for Sector - Health funds, you might want to consider passing on by Franklin Biotechnology Discovery A (FBDIX) as a possibility. FBDIX holds a Zacks Mutual Fund Rank of 4 (Sell), which is based on nine forecasting factors like size, cost, an
If investors are looking at the Large Cap Blend fund category, T. Rowe Price Cap Opportunity (PRCOX) could be a potential option. PRCOX holds a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on nine forecasting factors like size, cost, and past performance.
SPECIAL ALERT: The latest episode of the Zacks Ultimate Strategy Session will be available for viewing no later than this Thursday, September 9. Kevin Matras, Kevin Cook, Daniel Laboe, Dr. John Blank and Sheraz Mian will cover the investment landscape from several angle
The coronavirus outbreak has once again become a huge concern for the world’s largest economy. New cases are being registered in huge numbers among the unvaccinated people. Only 53% of the total US population is fully vaccinated, which means that it’s a long way to go to
Technology stocks were hanging on for slim gains, with the SPDR Technology Select Sector ETF (XLK) Tuesday rising 0.1% although the Philadelphia Semiconductor Index was falling 0.3% this afternoon.
Investors are a little on the edge about their investment choices in September given that the month has been historically considered the worst-performing for Wall Street. Meanwhile, market analysts expect a market correction in September.
Wall Street was moderately upbeat last week with the S&P 500 (0.58%), the Dow Jones (down 0.24%), the Nasdaq Composite (up 1.6%) and the Russell 2000 (up 0.7%) gaining moderately. The benchmark treasury yield jumped to 1.33% on September 3 from 1.29% on Aug 30.
Tuesday, September 7, 2021The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Facebook, Inc. (FB), AbbVie Inc. (ABBV), and 3M Company (MMM). These research repor
The Biden administration recently offered a $65 billion plan that U.S. officials say is aimed at combating the biological threats after the COVID-19 pandemic goes away. The next pandemic will likely be “substantially different” than Covid, and so the U.S. government has s